Determination of flunitrazepam in human plasma and urine by HPLC with mass spectrometry detection

Journal of Liquid Chromatography and Related Technologies

Volumn 31, Issue 16, 2008, Pages 2442-2454

  Vlase, Laurian ^a   Kiss, Béla ^a   Loghin, Felicia ^a   Leucuţa, Sorin E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Flunitrazepam; Liquid chromatography; Mass spectrometry; Plasma; Urine; Validation

Indexed keywords

ATMOSPHERIC PRESSURE; ATMOSPHERICS; CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; ION SOURCES; IONIZATION OF LIQUIDS; IONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; PLASMA (HUMAN); PLASMAS; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS;

ANALYTE; ANALYTICAL METHODS; ATMOSPHERIC PRESSURE CHEMICAL IONISATION; FLUNITRAZEPAM; HUMAN PLASMAS; ION-TRAP MASS SPECTROMETERS; LC/MS/MS; MULTIPLE-REACTION MONITORING; PLASMA; PLASMA SAMPLES; PROTEIN PRECIPITATION; RUN-TIME; SAMPLE PROCESSING; SELECTIVE LIQUID CHROMATOGRAPHY; URINE; VALIDATION;

BODY FLUIDS;

FLUNITRAZEPAM; PROTEIN;

ANALYTICAL EQUIPMENT; ARTICLE; ATMOSPHERIC PRESSURE; BLOOD ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MONITORING; PRECIPITATION; URINALYSIS;

EID: 50049105830     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070802319636     Document Type: Article

References (20)

1. Compton, E.M.; Volkow, N.D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006, 83S, S4-S7.
2. McCabe, S.E. Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of US. Drug Alcohol Depend. 2005, 79, 53-62.
3. Druid, H.; Holmgren, P.; Ahlner, J. Flunitrazepam: an evaluation of use, abuse and toxicity. Foren. Sci. Int. 2001, 122, 136-141.
4. Ohshima, T. A case of drug-facilitated sexual assault by the use of flunitrazepam. J. Clin. Foren. Med. 2006, 13, 44-45.
5. Hackett, J.; Elian, A.A. Extraction and analysis of flunitrazepam/ 7-aminoflunitrazepam in blood and urine by LC-PDA and GC-MS using butyl SPE columns. Foren. Sci. Int. 2006, 157, 156-162.
6. El Mahjoub, A.; Staub, C. Simultaneous determination of benzodiazepines in whole blood or serum by HPLC/DAD with a semi-micro column. J. Pharm. Biomed. Anal. 2000, 23, 447-458.
7. El Mahjoub, A.; Staub, C. High-performance liquid chromatographic method for the determination of benzodiazepines in plasma or serum using the column-switching technique. J. Chromatogr. B Biomed. Sci. Appl. 2000, 742 (2), 381-390.
8. Berthault, F.; Kintz, P.; Mangin, P. Simultaneous high-performance liquid chromatographic analysis of flunitrazepam and four metabolites in serum. J. Chromatogr. B Biomed. Appl. 1996, 685 (2), 383-387.
9. Benhamou-Batut, F.; Demotes-Mainard, F.; Labat, L.; Vincon, G.; Bannwarth, B. Determination of flunitrazepam in plasma by liquid chromatography. J. Pharm. Biomed. Anal. 1994, 12 (7), 931-936.
10. Smink, B.E.; Brandsma, J.E.; Dijkhuizen, A.; Lusthof, K.J.; de Gier, J.J.; Egberts, A.C.G.; Uges, D.R.A. Quantitative analysis of 33 benzodiazepines, metabolites and benzodiazepine-like substances in whole blood by liquid chromatography-(tandem) mass spectrometry. J. Chromatogr. B 2004, 811, 13-20.
11. Bugey, A.; Rudaz, S.; Staub, C. A fast LC-APCI/MS method for analysing benzodiazepines in whole blood using monolithic support. J. Chromatogr. B 2006, 832, 249-255.
12. Quintela, O.; Cruz, A.; de Castro, A.; Concheiro, M.; Lopez-Rivadulla, M. Liquid chromatography-electrospray ionization mass-spectrometry for the determination of nine selected benzodiazepines in human plasma and oral fluid. J. Chromatogr. B 2005, 825, 63-71.
13. Fuh, M.-R.; Lin, S.-W.; Chen, L.-L.; Lin, T.-Y. Determination of flunitrazepam and 7-aminoflunitrazepam in human urine by on-line solid phase extraction liquid chromatography-electrospray-tandem masss-pectrometry. Talanta 2007, 72, 1329-1335.
14. Macek, J.; Klíma, J.; Ptáček, P. Rapid determination of omeprazole in human plasma by protein precipitation and liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2007, 852, 282-287.
15. Pirnay, S.; Bouchonnet, S.; Herve, F.; Libong, D.; Milan, N.; d'Athis, P.; Baud, F.; Ricordel, I. Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study. J. Chromatogr. B 2004, 807, 335-342.
16. The European Agency for the Evaluation of Medicinal Products. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, London, UK, July 2001 (CPMP/EWP/QWP/1401/98).
17. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations, Rockville, USA, March 2003, http://www.fda.gov/cder/guidance/index.htm.
18. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry-Bioanalytical Method Validation, May 2001.
19. Souverain, S.; Rudaz, S.; Veuthey, J.-L. Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. J. Chromatogr. A 2004, 1058, 61-66.
20. Stüber, M.; Reemtsma, T. Evaluation of three calibration methods to compensate matrix effects in environmental analysis with LC-ESI-MS. Anal. Bioanal. Chem. 2004, 378, 910-916.